Pentraxin 3 as A Cardiovascular Marker in Primary Hyperparathyroidism
Journal Title: Journal of Endocrinology and Diabetes - Year 2018, Vol 5, Issue 4
Abstract
Aim: Pentraxin 3 (PTX3) is an acute-phase glycoprotein, which is increased in patients with cardiovascular disease (CVD) and considered as a predictor of CVD in the general population. Accumulating evidence suggests that even mild primary hyperparathyroidism (PHPT) has an elevated risk for CVD. We aimed to investigate plasma PTX3 levels before and after parathyroidectomy in patients with primary hyperparathyroidism and determine its relationship with cardiovascular risk factors Material and Method: Twenty-nine patients with PHPT and 26 healthy controls were enrolled in the study. Anthropometric and laboratory parameters were recorded both before and 6 months after parathyroidectomy. Serum PTX3 levels were measured using a human PTX3 enzyme-linked immunosorbent assay. Results: Plasma PTX3 concentrations were similar between before and after parathyroidectomy and control group (10.97 ± 16.0, 11.97 ± 11.49, 7.88 ± 9.48, respectively, p>0.05). Systolic blood pressure, diastolic blood pressure, carotid intima-media thickness (CIMT) and calcium, parathormone, fasting plasma glucose, alkaline phosphatase concentrations were higher in the PHPT group (p< 0.05). Creatinine and phosphorus concentrations were higher in the control group (p< 0.05). PTX3 was not correlated with cardi-metabolic risk factors except body mass index (BMI) (r2:0.414, p:0.0253). Conclusion: Plasma PTX3 was not increased as well was not changed after parathyroidectomy in patients with PHPT. The PTX3 was correlated with BMI; however, it was not associated with other cardio-metabolic risk factors including DBP, CIMT, and CRP. These findings might support PTX3 cannot be used as a cardio-metabolic risk marker in patients with PHPT.
Authors and Affiliations
Muhammed Kizilgul, Mustafa Calışkan, Ozgur Ozcelik, Selvihan Beysel
Keywords
Related Articles
- EP ID EP413535
- DOI 10.15226/2374-6890/5/4/001113
- Views 99
- Downloads 0
Steroidogenic Activity of Aldosterone-Producing Adenoma with and without KCNJ5 Gene Mutations, Comparing with that in Each Adherent Normal Tissue
Introduction: The steroidogenic activity in a KCNJ5-gene mutated aldosterone-producing adenoma (APA) was reported to be much stronger than that in an APA of the wild type, while it is still controversial. Objectives: We...
Strategies of Hyperglycemia Management among Patients with Diabetic Nephropathy, Renal Impairment, Hypertension and Lipid Disorders
Diabetic nephropathy, a microvascular complication, usually starts by the development of incipient nephropathy (microalbuminuria), then proteinuria, reduced glomerular filtration rate and finally renal impairment or Chro...
Pentraxin 3 as A Cardiovascular Marker in Primary Hyperparathyroidism
Aim: Pentraxin 3 (PTX3) is an acute-phase glycoprotein, which is increased in patients with cardiovascular disease (CVD) and considered as a predictor of CVD in the general population. Accumulating evidence suggests that...
Preliminary Examination of Olanzapine and Diet Interactions on Metabolism in a Female Macaque
Clinical data suggest that atypical antipsychotics such as Olanzapine (OLZ) induce significant metabolic changes that are serious side effects of their primary use. Since controlled human studies are problematic and rode...
Resistant Hypertension in Diabetes Mellitus
Diabetes Mellitus (DM) confers an increase of cardiovascular risk, independently from other conventional risk factors. The risk of cardiovascular events is 4-fold higher in patients with both diabetes and hypertension, c...